fluorouracil and Carcinoma, Signet Ring Cell
fluorouracil has been researched along with Carcinoma, Signet Ring Cell in 103 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Based upon preclinical data showing synergy with mTOR inhibition and platinum chemotherapy, this study explores the safety and tolerability of combining everolimus with mFOLFOX6 for patients with metastatic gastroesophageal adenocarcinoma." | 9.22 | Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma. ( Chao, J; Chung, S; Chung, V; Fakih, MG; Frankel, P; Koehler, S; Lau, SC; Leong, L; Lim, D; Luevanos, E; Ruel, N; Yeon, C, 2016) |
"We report a case in which weekly paclitaxel (TXL) administration was effective for gastric cancer with malignant ascites." | 7.71 | [Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report]. ( Ezaki, T; Ikegami, T; Ishida, T; Itoh, H; Kawaguchi, K; Kido, A; Nose, N; Sasaki, Y; Shimokawa, H, 2002) |
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases." | 5.39 | Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013) |
"Based upon preclinical data showing synergy with mTOR inhibition and platinum chemotherapy, this study explores the safety and tolerability of combining everolimus with mFOLFOX6 for patients with metastatic gastroesophageal adenocarcinoma." | 5.22 | Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma. ( Chao, J; Chung, S; Chung, V; Fakih, MG; Frankel, P; Koehler, S; Lau, SC; Leong, L; Lim, D; Luevanos, E; Ruel, N; Yeon, C, 2016) |
"The aim of this study was to determine whether the relative mRNA expressions of the thymidylate synthase (TYMS) and the excision repair cross-complementing 1 (ERCC1) genes are associated with in vitro chemosensitivity to 5-fluorouracil (5-FU) and oxaliplatin in colorectal cancer, respectively." | 3.77 | Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. ( Cho, YB; Choi, SH; Chun, HK; Chung, HJ; Kim, HC; Lee, WY; Yun, SH, 2011) |
"We describe our experience with a patient who had undifferentiated gastric carcinoma with extensive lymph node metastasis, including para-aortic lymph-node metastasis, and had a complete response to induction therapy with methotrexate plus 5-fluorouracil (sequential therapy with MTX, 5-FU, and Leucovorin) and secondary treatment with oral TS-1." | 3.73 | [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1]. ( Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M, 2005) |
"We report a case in which weekly paclitaxel (TXL) administration was effective for gastric cancer with malignant ascites." | 3.71 | [Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report]. ( Ezaki, T; Ikegami, T; Ishida, T; Itoh, H; Kawaguchi, K; Kido, A; Nose, N; Sasaki, Y; Shimokawa, H, 2002) |
"We consider that our observations in gastric cancer patients in our clinic can be useful in the future randomised trials to point the way to improved outcomes." | 2.79 | Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution. ( Coskun-Breuneval, M; Demirkasimoglu, T; Elgin, Y; Guney, Y; Kara, SP; Kucukpilakci, B; Misirlioglu, HC; Ozgen, A; Sanri, E; Ugur, VI, 2014) |
"Gastric cancer is the second most common among cancer-related deaths in the world." | 2.77 | Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution. ( Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M, 2012) |
"This oxaliplatin combined with ELF regimen shows good efficacy and acceptable safety in advanced gastric cancer patients." | 2.74 | [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer]. ( Lou, F; Pan, HM; Zhu, YH, 2009) |
"Of the 96 patients with gastric cancers, 21 underwent R0 resection and afterward received adjuvant FOLFOX chemotherapy." | 2.74 | [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer]. ( Dai, H; Yan, D, 2009) |
" This study was to investigate the efficacy and safety of oxaliplatin in combination with capecitabine as first-line chemotherapy for AGC patients." | 2.74 | [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer]. ( Dong, NN; Liu, ZF; Wang, MY; Zhang, Q, 2009) |
"We hypothesised that gastric cancer outcome could be improved with more effective and intensified postoperative chemoradiotherapy." | 2.73 | Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. ( Bartelink, H; Boot, H; Cats, A; Dubbelman, R; Jansen, EP; Verheij, M, 2007) |
"5-fluorouracil (5-FU) has been widely used for the treatment of gastrointestinal cancers." | 2.69 | [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers]. ( Horimi, T; Morita, S; Shirasaka, T; Takahashi, I; Takasaki, M; Tsuji, A, 1999) |
"From a global perspective, gastric cancer including cancer of the esophago-gastric junction is the fourth most common malignant tumor and the second-most common cause of cancer-related death." | 2.46 | [Diagnosis and treatment of gastric cancer]. ( Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G, 2010) |
"Patients with PM from colorectal cancer and PCI >20 that were treated with CRS and HIPEC experience a one year longer and doubled overall survival compared with open-close/debulking patients." | 1.56 | Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. ( Artursson, S; Birgisson, H; Cashin, P; Enblad, M; Ghanipour, L; Graf, W, 2020) |
"Metastatic and refractory gastric cancer (GC) are associated with a poor prognosis; therefore, the identification of prognostic factors and chemosensitivity markers is extremely important." | 1.43 | Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. ( Altan, B; Asao, T; Bai, T; Bao, P; Hara, K; Ide, M; Kimura, A; Kogure, N; Kuwano, H; Mochiki, E; Nishiyama, M; Ogata, K; Oyama, T; Suzuki, M; Toyomasu, Y; Yokobori, T, 2016) |
"A total of 196 stage II and III colon cancer patients were retrospectively enrolled in prospectively collected data." | 1.42 | T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. ( An, MS; Bae, KB; Choi, CS; Hong, KH; Hwang, JW; Kang, MS; Kim, BM; Kim, JH; Kim, KH; Oh, MK; Yoo, JH, 2015) |
"Signet ring cell gastric cancer (SRCGC) has very poor prognosis worldwide, and studying its molecular characteristics is urgent for improving the outcome." | 1.42 | Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. ( Cao, J; Feng, JG; Gu, LH; He, KF; Jin, KT; Li, GL; Qian, LJ; Su, XY; Teng, LS; Wang, HH; Xu, X; Xu, ZZ; Zhang, J; Zhou, Q, 2015) |
"The study included 405 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection and received adjuvant therapy between January 2008 and July 2009." | 1.40 | Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. ( Bae, JM; Choi, MG; Kang, WK; Kim, S; Lee, J; Lee, JH; Lee, SJ; Lim, DH; Lim, HY; Park, JO; Park, SH; Park, YS; Sohn, TS, 2014) |
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases." | 1.39 | Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013) |
"Colorectal carcinoma is rare in the paediatric population but is increasing in incidence." | 1.38 | Metastatic paediatric colorectal carcinoma. ( Kennedy, MJ; Larkin, JO; McCormick, P; Mehigan, B; Muldoon, C; Woods, R, 2012) |
"A total of 31 patients with advanced gastric cancer was included." | 1.38 | The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer. ( Bilici, A; Ercan, S; Gumus, M; Orcun, A; Seker, M; Ustaalioglu, BB; Yilmaz, BE, 2012) |
"The majority of patients with gastric cancer in developing countries present with advanced disease." | 1.38 | Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. ( Guven, M; Inal, A; Işikdogan, A; Kaplan, MA; Kuçukoner, M; Nas, N; Urakci, Z; Yunce, M, 2012) |
"We studied 26 gastric cancer patients with lymph node metastasis who underwent gastric resection at the Korea University Guro Hospital from Feb 2007 to July 2008." | 1.37 | Metastatic lymph node targeted chemosensitivity test for gastric cancer. ( Jang, YJ; Kim, CS; Kim, JH; Kim, SJ; Mok, YJ; Park, SH; Park, SS, 2011) |
"The gastric cancer was complicated by malignant pericardial effusion and pleural effusion as well as metastasis to the peripheral lymph nodes and bones." | 1.36 | A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy. ( Qin, YW; Xu, RL; Zhang, BL; Zheng, X, 2010) |
"We hypothesized that the sensitivity of gastric cancer to 5-FU treatment might be related to the rate of glucose transport (GLUT), and investigated the expressions of GLUT1, 2, 3, and 4 in two different gastric cancer cells (SNU-216, moderately differentiated gastric adenocarcinoma; and SNU-668, signet ring cell gastric carcinoma)." | 1.36 | Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells. ( Baik, HH; Cho, HY; Ha, E; Ha, TK; Hur, SJ; Kim, YH; Kwon, SJ; Suh, SI; Won, HJ, 2010) |
"104 patients with advanced gastric cancers were treated with capecitabine-based chemotherapy regimens from Sept." | 1.35 | [Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. ( Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD, 2009) |
"Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours." | 1.34 | [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007) |
"In vitro, human colon cancer cell lines were treated with anti-CEA MAb IgG1, hMN-14 (labetuzumab), to assess direct effects on proliferation, as well as antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC)." | 1.33 | Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft. ( Blumenthal, RD; Goldenberg, DM; Hansen, HJ; Hayes, MK; Horak, ID; Osorio, L, 2005) |
" Furthermore, she was administered tegafur/uracil (400 mg/day) 5 days weekly for pharmacokinetic modulating chemotherapy (PMC)." | 1.33 | [A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005) |
"Case 1 A 40-year-old female with gastric cancer located in the MULE area underwent total gastrectomy with D3 lymph node dissection on June 2, 1989." | 1.32 | [Two patients with metastatic ovarian tumor (Krukenberg's tumor) of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection]. ( Arai, K; Horiguchi, S; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Nishioka, K; Takahashi, K; Yamaguchi, T, 2003) |
"Six patients with gastric cancer, stage IIIA to IV, received intraabdominal cisplatin (CDDP) at laporotomy." | 1.31 | [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion]. ( Kagawa, R; Nakayama, N; Sakata, S; Tada, M; Yamaguchi, T, 2002) |
"Final diagnosis stated a multilocular metastasising gastric cancer with infiltration of bone, peritoneum and dura and signet-cell infiltration of the bone marrow." | 1.31 | [Hemorrhagic diathesis as initial symptom of stomach carcinoma]. ( Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH, 2000) |
"Nocturnal infusion of 5-fluorouracil (5-FU) combined with pamidronate was performed in a 62-year-old male gastric cancer patient with multiple bone metastasis." | 1.30 | [A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate]. ( Fukano, S; Furuya, Y; Kinugasa, T; Kohno, N; Maekawa, Y; Sekimoto, K; Toyokawa, A, 1998) |
"The role in colorectal cancer is less clear, although there are some reports that suggest a benefit." | 1.30 | Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer. ( Clingan, P; Horsell, KW; King, DW; Merten, S; Morris, DL, 1999) |
"Three cases of postoperative gastric cancer with peritoneal dissemination were treated by combined administration of CDDP, 5-FU and Lentinan." | 1.29 | [Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan]. ( Mio, H; Terabe, K, 1994) |
"A 41-year-old woman diagnosed as gastric cancer with peritoneal dissemination was admitted for operation." | 1.29 | [A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil]. ( Fukuda, I; Kishimoto, S; Kokufu, I; Miyake, Y, 1995) |
Research
Studies (103)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (18.45) | 18.2507 |
2000's | 31 (30.10) | 29.6817 |
2010's | 48 (46.60) | 24.3611 |
2020's | 5 (4.85) | 2.80 |
Authors
Authors | Studies |
---|---|
Otta-Oshiro, RJ | 1 |
Lista-Mateos, F | 1 |
Encinas-García, S | 1 |
Morales-García, S | 1 |
Núñez-Mora, C | 1 |
Nakajima, Y | 1 |
Kajiwara, A | 1 |
Sakaki, M | 1 |
Otoyama, Y | 1 |
Nishihara, S | 1 |
Suzuki, N | 1 |
Usami, T | 1 |
Nakatani, S | 1 |
Wang, T | 1 |
Yoshida, H | 1 |
Lin, YL | 1 |
Zhang, J | 3 |
Yan, FC | 1 |
Jiang, X | 1 |
Ma, R | 1 |
Yang, ZR | 1 |
Xu, HB | 1 |
Peng, Z | 1 |
Chen, Q | 1 |
Li, Y | 3 |
Kolla, BC | 1 |
Petersen, A | 1 |
Chengappa, M | 1 |
Gummadi, T | 1 |
Ganesan, C | 1 |
Gaertner, WB | 1 |
Blaes, A | 1 |
Henry, M | 1 |
Delavari, N | 1 |
Webber, J | 1 |
Birgisson, H | 1 |
Enblad, M | 1 |
Artursson, S | 1 |
Ghanipour, L | 1 |
Cashin, P | 1 |
Graf, W | 1 |
Kosmala, R | 1 |
Fokas, E | 1 |
Flentje, M | 1 |
Sauer, R | 2 |
Liersch, T | 2 |
Graeven, U | 1 |
Fietkau, R | 2 |
Hohenberger, W | 2 |
Arnold, D | 1 |
Hofheinz, RD | 1 |
Ghadimi, M | 1 |
Ströbel, P | 1 |
Staib, L | 1 |
Grabenbauer, GG | 1 |
Folprecht, G | 1 |
Kirste, S | 1 |
Uter, W | 1 |
Gall, C | 1 |
Rödel, C | 2 |
Polat, B | 1 |
Goense, L | 1 |
van Rossum, PSN | 1 |
Xi, M | 1 |
Maru, DM | 1 |
Carter, BW | 1 |
Meijer, GJ | 1 |
Ho, L | 1 |
van Hillegersberg, R | 1 |
Hofstetter, WL | 1 |
Lin, SH | 1 |
Rombouts, AJM | 1 |
Hugen, N | 1 |
Verhoeven, RHA | 1 |
Elferink, MAG | 1 |
Poortmans, PMP | 1 |
Nagtegaal, ID | 1 |
de Wilt, JHW | 1 |
Jiang, ZC | 1 |
Chi, Y | 1 |
Huelster, HL | 1 |
Hogan, MMS | 1 |
Resnick, MJ | 1 |
Wang, L | 2 |
Li, PF | 1 |
Geng, M | 2 |
Cao, YC | 2 |
Yin, YC | 2 |
Piessen, G | 1 |
Messager, M | 1 |
Le Malicot, K | 1 |
Robb, WB | 1 |
Di Fiore, F | 1 |
Guilbert, M | 1 |
Moreau, M | 1 |
Christophe, V | 1 |
Adenis, A | 1 |
Mariette, C | 1 |
Yoney, A | 1 |
Isikli, L | 1 |
Toiyama, Y | 1 |
Inoue, Y | 1 |
Saigusa, S | 1 |
Kawamura, M | 1 |
Kawamoto, A | 1 |
Okugawa, Y | 1 |
Hiro, J | 1 |
Tanaka, K | 1 |
Mohri, Y | 1 |
Kusunoki, M | 1 |
Wu, H | 1 |
He, YL | 1 |
Xu, JB | 1 |
Cai, SR | 1 |
Ma, JP | 1 |
Chen, CQ | 1 |
Zhang, XH | 1 |
Zhan, WH | 1 |
Kasliwal, MK | 1 |
Tan, LA | 1 |
O'Toole, JE | 1 |
Kaytan Saglam, E | 1 |
Yucel, S | 1 |
Balik, E | 1 |
Saglam, S | 1 |
Asoglu, O | 1 |
Yamaner, S | 1 |
Bugra, D | 1 |
Oral, EN | 1 |
Kizir, A | 1 |
Kapran, Y | 1 |
Sakar, B | 1 |
Akyuz, A | 1 |
Gulluoglu, M | 1 |
Lee, SJ | 1 |
Sohn, TS | 1 |
Lee, J | 2 |
Park, SH | 2 |
Park, JO | 2 |
Lim, DH | 1 |
Park, YS | 2 |
Lim, HY | 2 |
Choi, MG | 1 |
Lee, JH | 1 |
Bae, JM | 1 |
Kim, S | 1 |
Kang, WK | 2 |
Misirlioglu, HC | 1 |
Coskun-Breuneval, M | 1 |
Kucukpilakci, B | 1 |
Ugur, VI | 1 |
Elgin, Y | 1 |
Demirkasimoglu, T | 1 |
Kara, SP | 1 |
Ozgen, A | 1 |
Sanri, E | 1 |
Guney, Y | 1 |
Choe, JH | 1 |
Overman, MJ | 1 |
Fournier, KF | 1 |
Royal, RE | 1 |
Ohinata, A | 1 |
Rafeeq, S | 1 |
Beaty, K | 1 |
Phillips, JK | 1 |
Wolff, RA | 1 |
Mansfield, PF | 1 |
Eng, C | 1 |
Milovanov, V | 1 |
Sardi, A | 1 |
Ledakis, P | 1 |
Aydin, N | 1 |
Nieroda, C | 1 |
Sittig, M | 1 |
Nunez, M | 1 |
Gushchin, V | 1 |
An, MS | 1 |
Yoo, JH | 1 |
Kim, KH | 1 |
Bae, KB | 1 |
Choi, CS | 1 |
Hwang, JW | 1 |
Kim, JH | 3 |
Kim, BM | 1 |
Kang, MS | 1 |
Oh, MK | 1 |
Hong, KH | 1 |
Xu, X | 1 |
Qian, LJ | 1 |
Su, XY | 1 |
He, KF | 1 |
Jin, KT | 1 |
Gu, LH | 1 |
Feng, JG | 1 |
Li, GL | 1 |
Zhou, Q | 1 |
Xu, ZZ | 1 |
Wang, HH | 1 |
Cao, J | 1 |
Teng, LS | 1 |
Altan, B | 1 |
Yokobori, T | 1 |
Ide, M | 1 |
Mochiki, E | 1 |
Toyomasu, Y | 1 |
Kogure, N | 1 |
Kimura, A | 1 |
Hara, K | 1 |
Bai, T | 1 |
Bao, P | 1 |
Suzuki, M | 2 |
Ogata, K | 1 |
Asao, T | 1 |
Nishiyama, M | 1 |
Oyama, T | 1 |
Kuwano, H | 1 |
Chung, V | 1 |
Frankel, P | 1 |
Lim, D | 1 |
Yeon, C | 1 |
Leong, L | 1 |
Chao, J | 1 |
Ruel, N | 1 |
Luevanos, E | 1 |
Koehler, S | 1 |
Chung, S | 1 |
Lau, SC | 1 |
Fakih, MG | 1 |
Mizoshita, T | 1 |
Kataoka, H | 1 |
Kubota, E | 1 |
Okamoto, Y | 1 |
Shimura, T | 1 |
Mori, Y | 1 |
Wada, T | 1 |
Ogasawara, N | 1 |
Sasaki, M | 1 |
Kamiya, T | 1 |
Joh, T | 1 |
Xavier, MH | 1 |
Vergueiro, Tde R | 1 |
Vilar, EG | 1 |
Pinto, JM | 1 |
Issa, MC | 1 |
Pereira, GB | 1 |
Carocha, AP | 1 |
Jain, AK | 1 |
Motil, KJ | 1 |
Olutoye, OO | 1 |
Cope-Yokoyama, S | 1 |
Egler, RA | 1 |
Tatevian, N | 1 |
Lou, F | 1 |
Zhu, YH | 1 |
Pan, HM | 1 |
Yan, D | 1 |
Dai, H | 1 |
Xiao, Y | 1 |
Lu, M | 1 |
Li, J | 1 |
Zhang, XD | 1 |
Shen, L | 1 |
Dong, NN | 1 |
Wang, MY | 1 |
Zhang, Q | 1 |
Liu, ZF | 1 |
Qiu, MZ | 1 |
Teng, KY | 1 |
Ruan, DY | 1 |
Li, YH | 1 |
Chen, XQ | 1 |
Pan, ZZ | 1 |
He, YJ | 1 |
Wan, DS | 1 |
Xu, RH | 1 |
Jansen, EPM | 1 |
Boot, H | 2 |
Dubbelman, R | 2 |
Verheij, M | 2 |
Cats, A | 2 |
Kadikoylu, G | 1 |
Barutca, S | 1 |
Tataroglu, C | 1 |
Kafkas, S | 1 |
Erpek, H | 1 |
Meydan, N | 1 |
Yavasoglu, I | 1 |
Bolaman, Z | 1 |
Won, HJ | 1 |
Ha, TK | 1 |
Kwon, SJ | 1 |
Cho, HY | 1 |
Hur, SJ | 1 |
Baik, HH | 1 |
Suh, SI | 1 |
Ha, E | 1 |
Kim, YH | 1 |
Yoshitani, S | 1 |
Hosokawa, K | 1 |
Yokoi, M | 1 |
Kinami, S | 1 |
Omote, K | 1 |
Ueda, N | 1 |
Nakano, Y | 1 |
Kosaka, T | 1 |
Mastoraki, A | 1 |
Papanikolaou, IS | 1 |
Kanakis, D | 1 |
Safioleas, P | 1 |
Sakorafas, G | 1 |
Safioleas, M | 1 |
Kanagavel, D | 1 |
Pokataev, IA | 1 |
Fedyanin, MY | 1 |
Tryakin, AA | 1 |
Bazin, IS | 1 |
Narimanov, MN | 1 |
Yakovleva, ES | 1 |
Garin, AM | 1 |
Tjulandin, SA | 1 |
Sato, S | 1 |
Mukai, M | 1 |
Aneiros-Fernandez, J | 1 |
Husein-ElAhmed, H | 1 |
Arias-Santiago, S | 1 |
Escobar Gómez-Villalva, F | 1 |
Nicolae, A | 1 |
O'Valle Ravassa, F | 1 |
Aneiros-Cachaza, J | 1 |
Zhang, BL | 1 |
Xu, RL | 1 |
Zheng, X | 1 |
Qin, YW | 1 |
Lordick, F | 1 |
Grenacher, L | 1 |
Röcken, C | 1 |
Ebert, M | 1 |
Moehler, M | 1 |
Schumacher, G | 1 |
Jang, YJ | 1 |
Park, SS | 1 |
Kim, SJ | 1 |
Kim, CS | 1 |
Mok, YJ | 1 |
Eich, HT | 1 |
Stepien, A | 1 |
Zimmermann, C | 1 |
Hellmich, M | 1 |
Metzger, R | 1 |
Hölscher, A | 1 |
Müller, RP | 1 |
Karabay, CY | 1 |
Gecmen, C | 1 |
Aung, SM | 1 |
Guler, A | 1 |
Candan, O | 1 |
Batgerel, U | 1 |
Kalayci, A | 1 |
Kirma, C | 1 |
Takai, H | 1 |
Kondoh, E | 1 |
Sato, Y | 1 |
Kakui, K | 1 |
Tatsumi, K | 1 |
Konishi, I | 1 |
Wang, F | 1 |
Wang, Z | 2 |
Zhou, N | 1 |
An, X | 1 |
Xu, R | 1 |
He, Y | 1 |
Ioannidis, O | 1 |
Papaemmanouil, S | 1 |
Paraskevas, G | 1 |
Chatzopoulos, S | 1 |
Kotronis, A | 1 |
Papadimitriou, N | 1 |
Makrantonakis, A | 1 |
Kakoutis, E | 1 |
Cho, YB | 1 |
Chung, HJ | 1 |
Lee, WY | 1 |
Choi, SH | 1 |
Kim, HC | 1 |
Yun, SH | 1 |
Chun, HK | 1 |
Inal, A | 2 |
Kaplan, MA | 2 |
Kucukoner, M | 2 |
Isikdogan, A | 2 |
Roldán, AM | 1 |
Núñez, NF | 1 |
Grande, E | 1 |
García, AÁ | 1 |
Antón-Aparicio, LM | 1 |
Ferrand, FR | 1 |
Gontier, E | 1 |
Guymar, S | 1 |
Fagot, T | 1 |
Ceccaldi, B | 1 |
Malfuson, JV | 1 |
de Revel, T | 1 |
Chen, YG | 1 |
Kao, WY | 1 |
Tsai, SH | 1 |
Woods, R | 1 |
Larkin, JO | 1 |
Muldoon, C | 1 |
Kennedy, MJ | 1 |
Mehigan, B | 1 |
McCormick, P | 1 |
Vigliar, E | 1 |
Marino, G | 1 |
Matano, E | 2 |
Imbimbo, C | 1 |
Rossella, de C | 1 |
Insabato, L | 1 |
Bilici, A | 1 |
Ustaalioglu, BB | 1 |
Ercan, S | 1 |
Seker, M | 1 |
Yilmaz, BE | 1 |
Orcun, A | 1 |
Gumus, M | 1 |
Urakci, Z | 1 |
Guven, M | 1 |
Nas, N | 1 |
Yunce, M | 1 |
Hur, H | 1 |
Xuan, Y | 1 |
Kim, YB | 1 |
Lee, G | 1 |
Shim, W | 1 |
Yun, J | 1 |
Ham, IH | 1 |
Han, SU | 1 |
Liang, JW | 1 |
Zhou, ZX | 1 |
Zhang, XM | 1 |
Hu, JJ | 1 |
Zhao, P | 1 |
Kang, EJ | 1 |
Im, SA | 1 |
Oh, DY | 1 |
Han, SW | 1 |
Kim, JS | 1 |
Choi, IS | 1 |
Kim, JW | 1 |
Kim, YJ | 1 |
Kim, TY | 1 |
Lee, JS | 1 |
Bang, YJ | 1 |
Lee, KW | 1 |
Ishida, T | 1 |
Shimokawa, H | 1 |
Kawaguchi, K | 1 |
Nose, N | 1 |
Ikegami, T | 1 |
Itoh, H | 1 |
Kido, A | 1 |
Sasaki, Y | 1 |
Ezaki, T | 1 |
Kagawa, R | 1 |
Nakayama, N | 1 |
Yamaguchi, T | 3 |
Sakata, S | 1 |
Tada, M | 1 |
Segura Huerta, A | 1 |
Pérez-Fidalgo, JA | 1 |
López-Tendero, P | 1 |
Gironés Sarrió, R | 1 |
Aparicio Urtasun, J | 1 |
Nabeshima, S | 1 |
Kishihara, Y | 1 |
Nabeshima, A | 1 |
Yamaga, S | 1 |
Kinjo, M | 1 |
Kashiwagi, S | 1 |
Hayashi, J | 1 |
Nishioka, K | 1 |
Arai, K | 2 |
Iwasaki, Y | 2 |
Katayanagi, S | 1 |
Takahashi, K | 1 |
Matsumoto, H | 1 |
Miyamoto, H | 1 |
Horiguchi, S | 1 |
Leitman, M | 1 |
Baram, S | 1 |
Sidenko, S | 1 |
Abo-Kishk, I | 1 |
Peleg, E | 1 |
Vered, Z | 1 |
Harting, MT | 1 |
Blakely, ML | 1 |
Herzog, CE | 1 |
Lally, KP | 1 |
Ajani, JA | 1 |
Andrassy, RJ | 1 |
Blumenthal, RD | 1 |
Osorio, L | 1 |
Hayes, MK | 1 |
Horak, ID | 1 |
Hansen, HJ | 1 |
Goldenberg, DM | 1 |
Ishikawa, T | 1 |
Mizuno, K | 1 |
Togashi, T | 1 |
Watanabe, K | 1 |
Seki, K | 1 |
Ohta, H | 1 |
Yoshida, T | 1 |
Kamimura, T | 1 |
De Vita, F | 1 |
Orditura, M | 1 |
Bianco, R | 1 |
Carlomagno, C | 1 |
Infusino, S | 1 |
Damiano, V | 1 |
Simeone, E | 1 |
Diadema, MR | 1 |
Lieto, E | 1 |
Castellano, P | 1 |
Pepe, S | 1 |
De Placido, S | 1 |
Galizia, G | 1 |
Di Martino, N | 1 |
Ciardiello, F | 1 |
Catalano, G | 1 |
Bianco, AR | 1 |
Hiramatsu, K | 1 |
Mizukami, Y | 1 |
Momiyama, M | 1 |
Niimi, K | 1 |
Nagashima, T | 1 |
Martus, P | 1 |
Papadoupolos, T | 1 |
Füzesi, L | 1 |
Klimpfinger, M | 1 |
Raab, R | 1 |
Wittekind, C | 1 |
Kwon, JM | 1 |
Oh, SY | 1 |
Lee, HR | 1 |
Kim, HJ | 1 |
Park, BB | 1 |
Han, MJ | 1 |
Resnik, KS | 1 |
DiLeonardo, M | 1 |
Gibbons, G | 1 |
Jansen, EP | 1 |
Bartelink, H | 1 |
Mitsuno, M | 1 |
Kitajima, Y | 1 |
Ide, T | 1 |
Ohtaka, K | 1 |
Tanaka, M | 1 |
Satoh, S | 1 |
Miyazaki, K | 1 |
Mohile, SG | 1 |
Schleicher, L | 1 |
Petrylak, DP | 1 |
Fu, ZJ | 1 |
Wang, XY | 1 |
Tai, YH | 1 |
Bellman, B | 1 |
Gregory, NA | 1 |
Silvers, D | 1 |
Fountain, KS | 1 |
Bondar', GV | 1 |
Zabudkin, AF | 1 |
Bukhteev, SV | 1 |
Aizawa, K | 1 |
Muto, I | 1 |
Suzuki, S | 1 |
Tanaka, N | 1 |
Yabusaki, H | 2 |
Tanaka, S | 1 |
Katayanagi, N | 1 |
Suzuki, T | 1 |
Tanaka, O | 2 |
Muto, T | 1 |
Mio, H | 1 |
Terabe, K | 1 |
Fujishima, H | 1 |
Mitsugi, K | 1 |
Nakamura, M | 1 |
Yoshimatsu, H | 1 |
Nakano, S | 1 |
Niho, Y | 1 |
Murase, M | 1 |
Kondo, K | 1 |
Kodera, Y | 1 |
Kiriyama, K | 1 |
Akiyama, S | 1 |
Ito, K | 1 |
Yokoyama, Y | 1 |
Shirasaka, T | 2 |
Takagi, H | 1 |
Miyazaki, N | 1 |
Ohkura, H | 1 |
Kajimura, N | 1 |
Okazaki, N | 1 |
Kokufu, I | 1 |
Fukuda, I | 1 |
Miyake, Y | 1 |
Kishimoto, S | 1 |
Kitamura, M | 1 |
Kostandy, G | 1 |
Katapadi, M | 1 |
Pullarkat, V | 1 |
Manzi, G | 1 |
Salama, S | 1 |
Sosler, B | 1 |
Hussain, KM | 1 |
Noda, N | 1 |
Sano, T | 2 |
Shirao, K | 1 |
Ono, H | 1 |
Katai, H | 2 |
Sasako, M | 2 |
Maruyama, K | 2 |
Deeb, LS | 1 |
Yamout, BI | 1 |
Shamseddine, AI | 1 |
Shabb, NS | 1 |
Uthman, SM | 1 |
Muguruma, K | 1 |
Nakata, B | 1 |
Hirakawa, K | 1 |
Yamashita, Y | 1 |
Onoda, N | 1 |
Inoue, T | 1 |
Matsuoka, T | 1 |
Kato, Y | 1 |
Sowa, M | 1 |
Kuniyasu, T | 1 |
Nakamura, T | 1 |
Tabuchi, Y | 1 |
Kuroda, Y | 1 |
Maekawa, Y | 1 |
Furuya, Y | 1 |
Toyokawa, A | 1 |
Kinugasa, T | 1 |
Fukano, S | 1 |
Sekimoto, K | 1 |
Kohno, N | 1 |
Tsuji, A | 1 |
Morita, S | 1 |
Horimi, T | 1 |
Takasaki, M | 1 |
Takahashi, I | 1 |
Hosoya, Y | 1 |
Kitoh, Y | 1 |
Kobayashi, E | 1 |
Okabe, R | 1 |
Fujimura, A | 1 |
Kanazawa, K | 1 |
Horsell, KW | 1 |
Merten, S | 1 |
Clingan, P | 1 |
King, DW | 1 |
Morris, DL | 1 |
Tanabe, T | 1 |
Nashimoto, A | 1 |
Sasaki, J | 1 |
Sano, M | 1 |
Tsutsui, M | 1 |
Tsuchiya, Y | 1 |
Makino, H | 1 |
Akiyama, N | 1 |
Ohta, T | 1 |
Yang, TS | 1 |
Hsu, KC | 1 |
Tang, R | 1 |
Chang, TC | 1 |
Dempke, W | 1 |
von Poblozki, A | 1 |
Kellner, O | 1 |
Wolf, HH | 1 |
Schmoll, HJ | 1 |
Heidemann, J | 1 |
Gockel, HR | 1 |
Winde, G | 1 |
Herbst, H | 1 |
Domschke, W | 1 |
Lügering, N | 1 |
Clinical Trials (12)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rect[NCT00349076] | Phase 3 | 1,256 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)[NCT01717924] | 314 participants (Anticipated) | Interventional | 2012-10-31 | Recruiting | |||
A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study)[NCT00407186] | Phase 3 | 788 participants (Actual) | Interventional | 2007-01-11 | Active, not recruiting | ||
Randomized Phase 3 Study of Xelox(Capecitabine Plus Oxaliplatin) Followed by Maintenance Capecitabine or Observation in Patients With Advanced Gastric Adenocarcinoma[NCT02289547] | Phase 3 | 184 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
Total Neoadjuvant Therapy in Rectal Cancer Treatment[NCT04747951] | Phase 4 | 280 participants (Anticipated) | Interventional | 2020-10-30 | Recruiting | ||
Randomized Phase 2 Study Comparing Pathological Responses on Colorectal Cancer Metastases After Preoperative Treatment Combining Bevacizumab With FOLFOX or FOLFIRI[NCT01858649] | Phase 2 | 60 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors[NCT01858662] | Phase 2 | 4 participants (Actual) | Interventional | 2014-01-31 | Terminated (stopped due to due to poor recrutment) | ||
Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.[NCT03034473] | 200 participants (Actual) | Interventional | 2011-08-31 | Active, not recruiting | |||
Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy[NCT00855946] | 46 participants (Actual) | Observational | 2009-05-31 | Completed | |||
KCSP Trial of cONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After neoadjUvant Concurrent chemoraDiothErapy: A Multicenter, Randomized Controlled Trial (KONCLUDE Trial)[NCT02843191] | Phase 3 | 358 participants (Anticipated) | Interventional | 2016-12-31 | Recruiting | ||
Evaluation of an Alternative Schedule for CRLX101 Alone in Combination With Bevacizumab and in Combination With mFOLFOX6 in Subjects With Advanced Solid Tumor Malignancies[NCT02648711] | Phase 1 | 41 participants (Actual) | Interventional | 2015-10-31 | Terminated (stopped due to Company decision) | ||
Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
4 reviews available for fluorouracil and Carcinoma, Signet Ring Cell
Article | Year |
---|---|
Undiagnosed Case of Signet Ring Cell Colorectal Carcinoma: A Case Report and Review of the Literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2020 |
[Diagnosis and treatment of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endo | 2010 |
Signet-ring-cell carcinoma of stomach metastatic to the bladder: a case report with cytological and histological correlation and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cytodiagnosis; F | 2013 |
Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Car | 1997 |
Trials
19 trials available for fluorouracil and Carcinoma, Signet Ring Cell
Article | Year |
---|---|
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri | 2021 |
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2013 |
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2015 |
Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2014 |
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2016 |
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2009 |
[FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2009 |
[Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2009 |
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma | 2010 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2010 |
Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Female; Fl | 2011 |
Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2012 |
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; D | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom | 2005 |
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2007 |
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2007 |
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2007 |
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2007 |
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2007 |
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cel | 2007 |
[Arterial infusion chemotherapy for advanced gastric cancer by sequential MTX/5-FU].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Ad | 1996 |
[Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Other Studies
80 other studies available for fluorouracil and Carcinoma, Signet Ring Cell
Article | Year |
---|---|
Metachronous Signet Ring Cell Bladder Metastasis as First Sing of Cancer Recurrence.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adj | 2019 |
[Primary appendiceal signet ring cell carcinoma:a case report].
Topics: Appendiceal Neoplasms; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Female; Fluorouracil; Huma | 2019 |
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.
Topics: Animals; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Humans; Injections, Intraperitoneal; Mal | 2020 |
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2020 |
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Intravenous; Adolescent; Adult; Aged; Aged | 2020 |
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Che | 2018 |
Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Carcinoma, Signet Ring | 2018 |
[Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2018 |
Acute Renal Transplant Failure Secondary to an Obstructing Ileal Conduit Adenocarcinoma: Case Report and Literature Review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Disease Progress | 2019 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke | 2013 |
Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma?
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine | 2013 |
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto | 2013 |
[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cel | 2013 |
Intradural tumor recurrence after resection of extradural metastasis: a rare but potential complication of intraoperative durotomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; C | 2014 |
Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2014 |
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2015 |
Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Ch | 2015 |
T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carci | 2015 |
Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line.
Topics: Animals; Carcinoma, Signet Ring Cell; Cell Line, Tumor; Cell Proliferation; China; Drug Resistance, | 2015 |
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Apoptosis; Biomarke | 2016 |
Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Female; | 2008 |
Cutaneous metastasis of gastric adenocarcinoma: an exuberant and unusual clinical presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cachexia; Carcinoma, Signet Ring Cell; Etoposide; Fl | 2008 |
Colon cancer in a 16-year-old girl: signet-ring cell carcinoma without microsatellite instability--an unusual suspect.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Colonic Neo | 2009 |
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2009 |
[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Antineoplastic Combined Chemothe | 2009 |
Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.
Topics: Abdomen, Acute; Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bio | 2010 |
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Carcinoma, Signet Ring Cell; Cell Line, Tumor | 2010 |
[A case of anal canal carcinoma with systemic lymph node metastases successfully treated by bevacizumab+mFOLFOX6 therapy].
Topics: Anal Canal; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti | 2009 |
A case of signet ring carcinoma of the appendix: dilemmas in differential diagnosis and management.
Topics: Abdominal Pain; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Appendiceal Neoplasms; | 2010 |
Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer.
Topics: Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Signet Ring Cell; Cell Differentiation; Chemothe | 2010 |
Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma.
Topics: Aged; Antineoplastic Agents; Capecitabine; Carcinoma, Signet Ring Cell; Deoxycytidine; Docetaxel; Fl | 2010 |
A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cardiac Tamponade; Drug | 2010 |
Metastatic lymph node targeted chemosensitivity test for gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; An | 2011 |
Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcin | 2011 |
Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Coronary Vasospasm; Electrocardiograph | 2011 |
Disseminated intravascular coagulation as the presenting sign of gastric cancer during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Signet Ring | 2011 |
Primary Signet Ring Cell Anal Adenocarcinoma.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Signet Ring Cell; Col | 2012 |
Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carc | 2011 |
A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2012 |
Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma; Carcinoma, Signet | 2012 |
Nonspecific but significant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Signet Ring Cell; Colonic Neop | 2012 |
Metastatic paediatric colorectal carcinoma.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevac | 2012 |
The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carc | 2012 |
Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasm | 2012 |
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western; | 2013 |
[Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2012 |
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brid | 2013 |
[Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinom | 2002 |
[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2002 |
[Thirteen years' survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Cobalt Radio | 2003 |
Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis.
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, | 2003 |
[Two patients with metastatic ovarian tumor (Krukenberg's tumor) of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Carcinom | 2003 |
Transient left ventricular and right atrial thrombosis after 5-fluorouracil therapy.
Topics: Abdominal Neoplasms; Adolescent; Carcinoma, Signet Ring Cell; Echocardiography; Fluorouracil; Heart | 2004 |
Treatment issues in pediatric gastric adenocarcinoma.
Topics: Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Sig | 2004 |
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemo | 2005 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ri | 2005 |
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2005 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon | 2006 |
Treatment of metastatic urachal carcinoma in an elderly woman.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Com | 2008 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim | 2007 |
Sweat gland carcinoma with metastases to the skin: response to 5-fluorouracil chemotherapy.
Topics: Aged; Bone Marrow Diseases; Bone Neoplasms; Carcinoma, Signet Ring Cell; Facial Neoplasms; Fluoroura | 1995 |
[The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1994 |
Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.
Topics: Carcinoma, Signet Ring Cell; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Dr | 1994 |
[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cel | 1994 |
[A case of advanced gastric cancer complicated with multiple liver metastasis successfully treated with l-LV and 5-FU combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administrati | 1994 |
[The clinical effect of chemotherapy with 5-FU and low-dose CDDP in patients with advanced gastric cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1994 |
Semiautomated 14C-thymidine incorporation assay for in vitro screening of anticancer drug.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Signet Ring Cell; Cell Divis | 1993 |
[A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Femal | 1995 |
Skin metastases: an unusual presenting sign of gastric carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Doxorubicin; Female; Fl | 1996 |
A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; | 1996 |
[p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Apo | 1998 |
Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies; Antimetabolites, Antineoplastic; Carcino | 1998 |
[A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Diphosp | 1998 |
Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cell Di | 1999 |
Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer.
Topics: Abscess; Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; | 1999 |
[A case of advanced gastric cancer with abdominal para-aortic lymph node metastasis successfully treated with FLP therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Carcinoma, S | 1999 |
Colon carcinoma with synchronous ovarian metastasis--report and discussion of five cases.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplasti | 2000 |
Node-positive mucosal gastric cancer: a follow-up study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Female; Fluorourac | 2001 |
Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.
Topics: Abdominal Neoplasms; Aged; Back; Biopsy, Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differentia | 2002 |